Levemir is a Soft Tissue Implant in the Human Prescription Drug category. It is labeled and distributed by Dispensing Solutions, Inc.. The primary component is Insulin Detemir.
Product ID | 68258-8977_082bc713-cea6-4af8-b2be-65622cb897d0 |
NDC | 68258-8977 |
Product Type | Human Prescription Drug |
Proprietary Name | Levemir |
Generic Name | Insulin Detemir |
Dosage Form | Implant |
Route of Administration | SOFT TISSUE |
Marketing Start Date | 2006-03-27 |
Marketing Category | NDA / NDA |
Application Number | NDA021536 |
Labeler Name | Dispensing Solutions, Inc. |
Substance Name | INSULIN DETEMIR |
Active Ingredient Strength | 14 mg/mL |
Pharm Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 2006-03-27 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021536 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2006-03-27 |
Inactivation Date | 2019-10-29 |
Ingredient | Strength |
---|---|
INSULIN DETEMIR | 14.2 mg/mL |
SPL SET ID: | 2b8d9730-686b-444b-9941-7b5877255924 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
PHarm Class EPC | |
NUI Code |
NDC | Brand Name | Generic Name |
---|---|---|
0169-3687 | Levemir | insulin detemir |
0169-6432 | Levemir | insulin detemir |
0169-6438 | Levemir | insulin detemir |
50090-1276 | Levemir | insulin detemir |
50090-1475 | Levemir | insulin detemir |
50090-4501 | Levemir | insulin detemir |
68258-8977 | Levemir | insulin detemir |
70518-1387 | Levemir | insulin detemir |
70518-1462 | Levemir | insulin detemir |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
LEVEMIR 76468735 2808088 Live/Registered |
Novo Nordisk A/S 2002-11-07 |